News‎ > ‎News Feed‎ > ‎

NICE Smoking Cessation – mental health services: call for evidence

posted 10 Jul 2012, 07:03 by Damian Wood
We would like to draw your attention to the NICE public health guidance: smoking cessation – mental health services, on which a series of evidence reviews and an economic analysis are being conducted. We invite you to submit research and local information that could contribute to these reviews, particularly in relation to the following key questions set out in the scope:
Smoking cessation interventions in mental health services
  • How effective and cost effective are smoking cessation interventions in helping people to quit including interventions that:
    •  use varenicline 
    • target children and young people
    • target staff 
    • target carers partners, parents and other family members of mental health service users
  • How effective and cost effective are interventions in secondary care mental health settings to help people temporarily abstain from smoking?
  • How effective and cost effective are the current approaches used by secondary care mental health services to identify and refer people to stop-smoking services?
  • How effective and cost effective are the current approaches used by mental healthcare services to identify and provide people with smoking cessation information, advice and support?
  • What type of approaches are effective and cost effective at encouraging secondary care mental health professionals to record smoking status, offer smoking cessation information, advice and support, or to refer people to stop-smoking services?
  • How can community, primary and secondary care mental health service providers collaborate more effectively to provide seamless smoking cessation services?
  • What barriers and facilitators affect the delivery of effective interventions, including the views, perceptions and beliefs of people using mental health services; for example by age, diagnosis or ethnicity?
  • What are the effects of bupropion and varenicline use for smoking cessation on the mental and physical health of people using mental health services, including those who are on medication?
  • Are there any populations or circumstances where use is unsafe?
  • Smoke-free strategies and interventions
    • How effective and cost effective are specific strategies and interventions for ensuring compliance with smoke-free legislation and local smoke-free policies in mental health settings?
    • What factors encourage or discourage compliance with smoke-free policies in mental health settings – including Organisational factors that encourage or discourage compliance with smoke-free policies in those settings The views, perceptions and beliefs of people who visit mental healthcare settings; for example, parents, carers or families?
NICE are interested in a broad range of different types of information, including natural experiments (such as studies on changing transport policies), local process and evaluation reports, scrutiny reports, community plans or strategy reports and local or national government reports, alongside more traditional quantitative and qualitative evidence. NICE are particularly interested in identifying studies that have been published or any ongoing research that is being conducted in the UK that relates to the questions outlined above. NICE is also interested in evidence related to child and adolescent mental health services (CAMHS) and evidence that may help to better promote equality of opportunity relating to age, disability, gender, gender identity, ethnicity, religion and belief, sexual orientation or socio-economic status. Subgroups that may be missed by conventional services are of particular interest, for example people with learning difficulties, the prison population, travellers, refugees and recent migrants To submit evidence, please complete the attached form and return it, with an electronic copy (preferred) or full reference details, to href=""> by 5pm on Wednesday 18th July. Our deadline is set before that of NICE to allow time to consider all evidence received and to draft an official response with review from the RCPCH Clinical Standards Committee. Responses received after this deadline will not be included in the RCPCH response to this consultation If you wish to submit relevant unpublished information or research, please highlight which sections are confidential by using a highlighter pen or the highlighter function in word. Please refer to section 4.4 of the NICE Process Manual for further information on submissions of confidential material

The only type of material NICE are not interested in is unsubstantiated or non evidence based opinion / discussion pieces or promotional material. Please ensure that permission from the copyright holder has been obtained prior to sending us any paper or electronic copies.  We are sending information on this consultation to the following groups and individuals:

·         RCPCH Consultation Panel members with an interest in community child health, general paediatrics, child mental health, neonates

·         British Association for Community Child Health

·         British Association of General Paediatrics

·         British Association of Perinatal Medicine

·         British Paediatric Mental Health Group

·         British Society for Paediatric and Adolescent Rheumatology

·         Community Child Health CSAC

·         General Paediatrics CSAC

·         George Still Forum - National Paediatric ADHD Network Group

·         Neonatal Medicine CSAC

·         Young People's Health Special Interest Group

f you have any questions please contact the Clinical Standards team. We thank you for your help in advance.

For a full list of current consultations, please go to

Best wishes
Dr Jan Dudley                                                   
Clinical Standards Committee Chair, RCPCH